BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ZBTB7A
,
Fatty acid metabolic process
,
Inflammatory disorder
,
Lymphocyte
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Multiple myeloma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
IGHD
CCND1
IGL
IGHA1
IGHM
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_BRCA1_PCC_NETWORK
PILON_KLF1_TARGETS_DN
CAIRO_HEPATOBLASTOMA_CLASSES_UP
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
PUJANA_CHEK2_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Smoldering myeloma and monoclonal gammopathy of undetermined significance (MGUS) plasma cells
Osteonecrosis of the jaw (ONJ) in Multiple Myeloma (MM) patients
Bone marrow plasma cells from multiple myeloma patients
Myeloma versus other lymphoma cell lines
Bone marrow from multiple myeloma patients with and without lytic lesions
Explore Curated Studies Results
Literature
Most Relevant Literature
Bispecific antibodies in the treatment of multiple myeloma.
Talquetamab in multiple myeloma.
Perspectives on the Treatment of Multiple Myeloma.
Effects of methane emissions on multiple myeloma-related mortality rates: A World Health Organizatio…
Management of Newly Diagnosed Multiple Myeloma Today, and in the Future.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Multiple Myeloma
Denosumab for Smoldering Multiple Myeloma
The Molecular Characterization of Multiple Myeloma at Relapse
Multiple Myeloma Molecular Monitoring Study
VitD3 Supplementation in Patients With Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ